ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2020 Congress

July 12-14, 2020. Virtual Congress.

View by Title View by Number View Themes
Jump to:  View All • a b c d [e] f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: PB2486

    E-selectin Inhibitor Is Superior to LMWH for Treatment of Experimental Venous Thrombosis

    D. Myers, Jr1, J.-J. Ning2, P. Lester1, R. Adili1, A. Hawley1, L. Durham1, V. Dunivant1, G. Reynolds1, K. Crego1, S. Sood1, R. Sigler1, W. Fogler3, J. Magnani3, M. Holinstat1, T. Wakefield1

  • Abstract Number: PB0152

    Early Indicators of Thromboembolic Events Caused by Prolonged Tourniquet Application: A Rat Model

    J. Chung1,2, O. Mian2,3, A. Chan2,4, D. Matino2,4

  • Abstract Number: PB2437

    Early Physiotherapy Intervention Reduces the Long Term Effects of Venous Thromboembolism and Promotes an Improved Quality of Life: Results from a Pilot Study

    R. Lewis1, C. Entwistle1, M. Robinson2

  • Abstract Number: PB2536

    Early Plasma Transfusion and Maternal Outcomes in Women with Persistent Postpartum Haemorrhage: Does the Amount of Resuscitation Fluids Matter?

    C. Caram-Deelder1, D. Henriquez2, S. le Cessie2, J. Zwart3, J. van Roosmalen4, H. Eikenboom2, C. So-Osman5, L. van de Watering5, J.J. Zwaginga2, A. Koopman-van Gemert6, K. Bloemenkamp2, J.G. van der Bom1, TeMpOH-1

  • Abstract Number: PB1170

    Economic Burden Associated with Vaso-Occlusive Crisis Management in Patients with Sickle Cell Disease

    A. Oladapo1, E. Swallow2, A. Briggs2, M.L. Zichlin2, B. Mellgård1

  • Abstract Number: PB2407

    Edoxaban for the Long-Term Therapy of Venous Thromboembolism in Real-Life RIETE Registry

    G. Camporese1, P. Simioni2, P. Di Micco3, C. Fernández-Capitán4, A. Rivas5, C. Font6, J.C. Sahuquillo7, P. Villares8, P. Prandoni1, M. Monreal9

  • Abstract Number: PB2409

    Edoxaban Treatment of Venous Thromboembolism in Routine Clinical Practice in the Non-Interventional Global ETNA-VTE Program: A Sub-Analysis by Age Groups

    G. Agnelli1, M. Nakamura2, K.-M. Chiu3,4, W.-I. Choi5, P. Reimitz6, C. Chen7, M. Unverdorben7, A. Cohen8

  • Abstract Number: PB0554

    Effect of Activated Charcoal in Removing Interference in Thrombophilia Assays: Resistance to Activated Protein C, Activity of Coagulation Factor VIII and Antithrombin Activity

    S. Margetić1, I. Ćelap1, S. Šupraha-Goreta2, J. Buben3, R. Mihić1

  • Abstract Number: PB0549

    Effect of Antiepileptic Therapy on Platelet Aggregation

    I. Ćelap, S. Margetić, R. Mihić

  • Abstract Number: PB2395

    Effect of Antiplatelet Therapy on Clinical Outcome of Patients Treated with Anticoagulation for Acute Venous Thromboembolism

    A.I. Casanegra1, R.D. McBane1, D.T. Vlazny1, D.E. Houghton1, D.O. Hodge2, D.A. Froehling1, L.G. Peterson1, W.E. Wysokinski1

  • Abstract Number: PB0762

    Effect of B-Mode Ultrasound-Guided Pulsed – High Intensity Focused Ultrasound-Mediated Inertial Cavitation Thrombolytic Therapy Accompanied by Air-Contained Sonicated Dextrose Albumin Microbubbles Administration on Embolic Artery Occlusion

    H. Mehrad1, M. Farhoudi2

  • Abstract Number: PB0044

    Effect of BTK Inhibition on Platelet-mediated Inflammation in an Obese Rhesus Macaque Model of Early Atherosclerosis

    T. Kohs1, S. Olson2, A. Xie2, J. Hodovan2, M. Muller2, C. McArthur2, J. Johnson2, M. Wallisch2, C. Lorentz2, N. Verbout2, P. Kievit2, J. Aslan2, O. McCarty2, J. Lindner2, J. Shatzel2

  • Abstract Number: PB1819

    Effect of cART on Platelet:Lymphocyte Ratio in HIV Patients Initiating Treatment

    H. Omunakwe1,2, B. Moore-Igwe3, O. Maduka4,5, E.M. Eze3, S.G. Christian3

  • Abstract Number: PB0510

    Effect of Dabigatran versus Enoxaparin on Blood Coagulation using the Viscoelastic Coagulation Test

    V.M. Silva1, C. Cavalheiro2, C.C. Strunz1

  • Abstract Number: PB1221

    Effect of Foot Bath on the Plasma Concentration of Plasminogen Activator Inhibitor-1 Produced by Endothelial Cells in Healthy Subjects

    T. Hayashi1, A. Tamada2

  • Abstract Number: PB1839

    Effect of Human Myeloperoxidase on Ca2+-response, Membrane Conductivity and Phosphatidylserine Exposure on Platelet Surface

    E. Shamova1, A. Kokhan1, I. Gorudko1, D. Grigorieva1, F. Balabin2, A. Sokolov3,4, A. Sveshnikova2

  • Abstract Number: PB1897

    Effect of Immune-Purified aβ2-Glycoprotein I (aβ2GPI) and Anti Phosphatidylserine/Prothrombin (aPS/PT) Antibodies on Thrombin Generation

    E. Bison, E. Pontara, M. Cattini, C.-Y. Cheng, G. Denas, V. Pengo

  • Abstract Number: PB0217

    Effect of Mg(II) Ion on the Interaction of Coagulation Factors with Phospholipid Membranes

    Y. Shikamoto1, T. Morita2, H. Mizuno3, K. Mori1

  • Abstract Number: PB1113

    Effect of Oral Anticoagulant Use on Surgical Delay and Outcomes in Hip Fracture Patients: A Systematic Review and Meta-Analysis

    Y. Xu1, D. You2, B. Ponich2, H. Krzyzaniak2, P. Ronksley2, L. Skeith2, P. Schneider2, M. Carrier1

  • Abstract Number: PB2054

    Effect of Patient and Surgery Characteristics on Clinical Outcomes in the Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) Study

    K. MacDougall1, J. Douketis2, N. Li2, N. Clark3, A. Tafur4, J. D'Astous5, J. Duncan2, S. Schulman2, A. Spyropoulos6

  • Abstract Number: PB0025

    Effect of Phosphomimetic Endothelial Nitric Oxide Synthase – Loaded Microbubbles-Mediated Transfection Therapy using B-Mode Ultrasound-Guided Focused – Low­ Level Confocal Dual-Pulse Electrohydraulic Shock Waves on Early Stage Atherosclerosis

    H. Mehrad1, A. Foletti2

  • Abstract Number: PB0045

    Effect of Photobiomodulation Therapy on Arterial Biomechanical Parameters in a Rabbit Carotid Artery Model of Early Stage Atherosclerosis

    H. Mehrad1, L. Kazemi2

  • Abstract Number: PB0046

    Effect of Photodynamic Therapy on Arterial Biomechanical Parameters in a Rabbit Carotid Artery Model of Neointimal Hyperplasia

    H. Mehrad1, A. Najafzadeh2

  • Abstract Number: PB0097

    Effect of Pulsatility on Thrombosis Modelling in Cerebral Aneurysms

    S. Hume1,2, I. Tshimanga3, W.-H. Ho4, M. Ngoepe5

  • Abstract Number: PB1116

    Effect of rFVIIa on Thromboelastogram Parameters in Haemophilia A Patients with Inhibitor

    V. Krasivska1, O. Stasyshyn2, M. Semerak2, O. Tushnytskyi3

  • Abstract Number: PB0763

    Effect of Streptokinase-Loaded Microbubbles-Mediated B-Mode Ultrasound-Guided Sono-Photomechanic Combination Thrombolytic Therapy on Atherothrombotic Stenosis

    H. Mehrad1, M. Farhoudi2

  • Abstract Number: PB1430

    Effect of Synthetic Inhibitors on HIT Antigenic Complex – Therapeutic Approach Alternative to Anticoagulation

    J.N. Kizhakkedathu1, C. La2, M.T. Kalathottukaren3, S.V. Yarovoi4, V. Hayes5, G.T. Koma5, S. Abbina1, J.H. Morrissey6, C.A. Haynes7, D.B. Cines4, L. Rauova5,8

  • Abstract Number: PB0807

    Effect of the First Factor VIII Infusions on Immunological Biomarkers in Children with Hemophilia A: Results from the HEMFIL Study

    L. Lemos Jardim1,2, L. Maira Moura de Oliveira1, M. Portugal Santana3, M. Hermida Cerqueira4, C. Santos Lorenzato5, V. Karla Brognoli Franco6, L. Werneck Zuccherato1, S. Meireles Rezende1, D. Gonçalves Chaves3

  • Abstract Number: PB1636

    Effect of Three Types of Mixed Anesthesia (MMB) for Platelet Function

    T. Kano, Y. Suganuma, K. Ikemoto, C. Ichinose, T. Matsui, K. Kondo

  • Abstract Number: PB0581

    Effect of Vitamin K Antagonist Therapy on the Dynamics of Hypercoagulation Syndrome in Patients with Deep Vein Thrombosis

    N. Vorobyeva, A. Alexseeva

  • Abstract Number: PB0351

    Effect of Warfarin Addition in Diabetic Foot Ulcer Patients Receiving Cilostazol In Mohammad Hoesin Hospital, South Sumatera, Indonesia

    M. Syahrir, E.S. Maksudin, Y. Tanta, A. Shahab

  • Abstract Number: PB2412

    Effectiveness and Safety of Apixaban for Treatment of Venous Thromboembolism in a Large Daily Practice Cohort

    S.V. Hendriks1,2, F.A. Klok1, W.J.E. Stenger1, A.T.A. Mairuhu2, J. Eikenboom1, J. Fogteloo3, M.V. Huisman1

  • Abstract Number: PB2166

    Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Ph-negative Myeloproliferative Neoplasms and Venous Thromboembolism

    V. De Stefano1, S. Betti2, T. Za1, A. Ciminello1, F. Bartolomei1, S. Ceglie1, F. Ramundo1, F. Di Landro1, P. Chiusolo1, E. Rossi1, T. Barbui3

  • Abstract Number: PB2113

    Effectiveness and Safety of Enoxaparin in Patients with Active Cancer and Venous Thromboembolism (VTE): A Systematic Literature Review

    J. Shan1, T. Sayre2, K. Hofer3, E.T. Shojaei3

  • Abstract Number: PB1310

    Effectiveness and Safety of Primary Thromboprophylaxis in Pediatric Renal Transplant: a Systematic Review of the Literature and Meta-Analysis

    A. Al-Huniti, C. Malcolmson, C.W. Toeh, V. Langlois, A. Lorenzo, S. Williams, L. Brandao

  • Abstract Number: PB2211

    Effectiveness and Safety of Pulmonary Rehabilitation to Reduce Functional Impairment Based on the Post-PE Syndrome

    G.J.A.M. Boon1, S.M.J. Janssen2, S. Barco3,4, H.J. Bogaard5, W. Ghanima6, L.J.M. Kroft7, L.J. Meijboom8, M.K. Ninaber9, E.J. Nossent10, P. Symersky11, H.W. Vliegen12, A. Vonk Noordegraaf10, M.V. Huisman1, B. Siegerink13,14, J.J. Abbink2, F.A. Klok1

  • Abstract Number: PB2171

    Effectiveness and Safety of Rivaroxaban in Patients with Cancer-associated Venous Thromboembolism

    O.S. Costa1,2, C.G. Kohn2,3, G.H. Lyman4, N.M. Kuderer5, T.J. Bunz6, C.I. Coleman1,2

  • Abstract Number: PB1226

    Effectiveness of a Self-management Program in the Treatment Control of Oral Anticoagulants Antivitamin K

    A. Vall1, M. Constans1, A. Altes1, R. Santiago2, C. Motllo2, R. López2

  • Abstract Number: PB2382

    Effectiveness of Implementing a Prophylaxis Protocol for Thromboembolic Events in Patients Admitted to a Tertiary Hospital

    M. Amorim de Oliveira, A. Haddad, C. Ferraz, A. Cerqueira, A. Godomiczer, C. Carvalho, A.L. Cascardo Marins, L.E. Carpenter

  • Abstract Number: PB2384

    Effectiveness of Thromboprophylaxis in the Prevention of Peripherally Inserted Central Catheter (PICC) Associated Venous Thromboembolism in Pediatric Patients: A Case-control Study

    M. Speckert1,2, S. Lamontagne1, K. Tang3, E. Simpson1,2

  • Abstract Number: PB0669

    Effects of Anticoagulants and Common Interfering Substances on Four Commercially Available dRVVT Assays

    A. Sadeghi-Khomami1, D. Lamont2, M. Boylan2, R. Clarke2, N. Kesavan2, C. Douglas2, K. Black2

  • Abstract Number: PB0181

    Effects of Anticoagulants on Fibrin Clot Structure: A Comparison between Vitamin K Antagonists and FXa inhibitors

    J. S. Gauer1, E. Page1, N. Riva2, A. Gatt2, H. Philippou1, M. Makris3, R.A.S. Ariens1

  • Abstract Number: PB2200

    Effects of Body Mass Index on the Human Plasma Proteome – Potential Drivers of Obesity-related Cardiovascular Disease?

    L. Goudswaard1,2,3, J.A. Bell2,3, D.M. Hughes3, K. Walter4, N. Soranzo4, A. Adam Butterworth5, I. Hers1, N.J. Timpson2,3

  • Abstract Number: PB0371

    Effects of Chemotherapy on Extracellular Vesicles and Coagulation Activation in Advanced Colorectal Cancer Patients

    L. Traby, H.C. Puhr, M. Kollars, O. Steinbrecher, G. Prager, W. Scheithauer, G. Kornek, P.A. Kyrle, S. Eichinger

  • Abstract Number: PB1660

    Effects of GPVI on Clot Structure: Reduction in Procoagulant Platelets in GPVI-Deficient Clots

    J. S. Gauer1, C. Duval1, S. Baker1,2, R.-G. Xu1, A. Slater3, E. Martin3, S.P. Watson3, R.A.S. Ariëns1

  • Abstract Number: PB0150

    Effects of Hibernation on the Platelet Proteome of 13-lined Ground Squirrels

    S. Cooper1, J. Cunliffe2, P. Wilmarth2, L. David2, J. Aslan2

  • Abstract Number: PB0716

    Effects of Lysine-Containing Peptides Treatment on FXIII Activity and Fibrinogen Level of Metabolic Disorders

    T. Shubina, T. Obergan

  • Abstract Number: PB0254

    Effects of Plasmin on Factor XII Structure and Activation

    I. Ivanov, A. Shamanaev, M.-F. Sun, D. Gailani

  • Abstract Number: PB0572

    Effects of Rivaroxaban on Thrombophilia Screening Tests – Results from a UK NEQAS (Blood Coagulation) Exercise

    I. Jennings, S. Kitchen, D. Kitchen, S. Munroe-Peart, A. Lowe, L. Brown, I. Walker

  • Abstract Number: PB0707

    Effects of Squalene-Adenosine Nanoparticles on Platelet Aggregation, Thrombin Generation and Endothelial Cells

    V. Maloteau1, M. Vandeputte1, M. Varna2, P. Couvreur2, J.-M. Dogné1,3, J. Laloy1,3

  • Abstract Number: PB1817

    Effects of the Bacterial Toxin Cytotoxic Necrotising Factor 1 on Platelet Function

    A. Chacko1, D. Riley1, J. Wei2, A. Colarusso3, M.L. Tutino3, F. Rivero1

  • Abstract Number: PB0930

    Efficacy and Safety of a 21-Day Individualized Dosing Interval in Patients with Hemophilia B Treated with rIX-FP

    E. Santagostino1, T. Lissitchkov2, A. Nagao3, A. Lubetsky4, L.M. Lepatan5, K. Nogami6, W. Seifert7, Y. Li8, I. Pabinger9

  • Abstract Number: PB0876

    Efficacy and Safety of Antihemophilic Factor (Recombinant) in Previously Treated Chinese Patients with Severe or Moderately Severe Hemophilia A: Results from a Phase 4 Study

    Y. Zhao1, Y. Hu2, J. Jin3, X. Zhao4, X. Wang5, R. Wu6, D. Wu7, R. Yang8, F. Yang9, Q. Hu10, J. Wang11, H. Fang12, W. Engl13

  • Abstract Number: PB2378

    Efficacy and Safety of Apixaban for the Primary Prevention of VTE among Patients with Gastrointestinal Cancers: A Post-hoc Analysis of the AVERT Trial

    D. Ladha, R. Mallick, P. Wells, M. Carrier

  • Abstract Number: PB0916

    Efficacy and Safety of BAY 94-9027 Prophylaxis for ≥5 Years: Outcomes in 36 Patients from the PROTECT VIII Extension Study

    P.A. Holme1, R. Klamroth2, W. Miesbach3, M. Wang4, M.E. Mancuso5, M.T. Reding6

  • Abstract Number: PB0302

    Efficacy and Safety of Ciraparantag in Reversing Apixaban and Rivaroxaban as Measured by Whole Blood Clotting Time in Healthy Adults

    J. Ansell1, S. Bakhru2, S. Villano3, X. Luo3

  • Abstract Number: OC 12.1

    Efficacy and Safety of Dabigatran Etexilate for Treatment of Venous Thromboembolism in Paediatric Patients Aged from Birth to < 2 Years - Results of the DIVERSITY Trial

    J. Halton1, L. Brandão2, M. Luciani3, L. Bomgaars4, E. Chalmers5, L. Mitchell6, I. Nurmeev7, A. Sharathkumar8, P. Svirin9, K. Gorbatikov10, I. Tartakovsky11, M. Simetzberger12, F. Huang13, Z. Sun14, J. Kreuzer15, S. Gropper16, P. Reilly17, M. Brueckmann11, M. Albisetti18, on Behalf of the Study Investigators

  • Abstract Number: PB1176

    Efficacy and Safety of Fibrinogen Concentrate for On-Demand Treatment of Acute Bleeding and Surgical Prophylaxis in Pediatric Patients with Congenital Fibrinogen Deficiency: Results from the FORMA-04 Study

    S.D. Lohade1, F. D'Souza2, G.S. Latha3, C. Khayat4, O. Zekavat5, B.A. Schwartz6, I. Kruzhkova7, C. Solomon7, S. Knaub7, F. Peyvandi8

  • Abstract Number: PB2520

    Efficacy and Safety of Low-Molecular-Weight Heparin for the Prevention of Pregnancy-Related Recurrent Venous Thromboembolism and Obstetrical Complications

    M. Abbattista1, I. Martinelli1, F. Gianniello1, A. Artoni1, P. Bucciarelli1, M. Capecchi2, F. Peyvandi2

  • Abstract Number: PB2361

    Efficacy and Safety of Pre-Operative Insertion of Inferior Vena Cava Filter in Patients Undergoing Bariatric Surgery: A Systematic Review

    R. Ikesaka1, B. Kaur2, M. Crowther1, A. Rajasekhar3

  • Abstract Number: PB0155

    Efficacy and Safety of Prothrombin Complex Concentrate in Obstetric Hemorrhage

    A. Ronenson1, E. Shifman2, A. Kulikov3

  • Abstract Number: PB1336

    Efficacy and Safety of Romiplostim in Children with Chronic and Persistent Immune Thrombocytopenic Purpura

    M. Bordbar, M. Karimi

  • Abstract Number: PB2247

    Efficacy and Safety Profile of Direct Oral Anticoagulants in Consecutive Patients with Severe Hereditary Thrombophilia: A Single-centre Cohort Study

    E. Campello1, C. Simion1, L. Spiezia1, D. Tormene1, G. Camporese2, G. Saggiorato1, F. Dalla Valle1, P. Simioni1

  • Abstract Number: PB0921

    Efficacy and Target Joint Resolution with Pharmacokinetic-Guided Rurioctocog Alfa Pegol Prophylaxis Targeting Two Factor VIII trough Levels in Patients with Severe Hemophilia A: Post-Hoc Analysis of the Phase 3 PROPEL Trial

    P. Collins1, J. Windyga2, M. Escobar3, H.M. Ibrahim4, J.C.M. Lam5, S.D. Tangada6, W. Engl7, I. Honauer8, A. Fernandez8, H.-Y. Lee8, R. Klamroth9, C. Escuriola-Ettingshausen10

  • Abstract Number: PB1392

    Efficacy of Antiplatelet Therapy in Patients with Acute Ischemic Stroke Treated with Acetylsalicylic Acid

    L. Bultasova1, Z. Hajsmanova1, P. Sigutova1, V. Rohan2, J. Polivka2

  • Abstract Number: PB1500

    Efficacy of Novoseven in the Treatment of Bleeding Episodes During Glanzmann´s Thrombasthenia

    R. Messaoudi, Z.Zouaoui , H.Touhami

  • Abstract Number: PB1023

    Efficacy of Platelet-rich Plasma in the Treatment of Hemophilic Arthropathy

    P. Eshghi1, F. Malek1, B. Habibpanah1, H. Davoudabadifarahani2

  • Abstract Number: PB1877

    Efficacy of Preemptive Subcutaneous Rituximab in Immune-Mediated Thrombotic Thrombocytopenic Purpura: A Study of 12 Cases

    M. Delrue1,2, M.-T. Baylatry3, A.-C. Joly3, Z. Mmarjanovic3, N. El-Khoury-Hanna4, F. Feger5, A. Veyradier1,2, A. Stepanian1,2, P. Coppo6,7

  • Abstract Number: PB2095

    Efficacy of Primary Thromboprophylaxis Agents (PTA) in Multiple Myeloma (MM) Treated with Immunomodulators (IMiD): A Network Meta-Analysis

    P.A. Haddad, D. Hammoud, K. Gallagher

  • Abstract Number: PB2458

    Efficacy of Reversible Factor Xa Inhibitors is Related to the Level of Factor VIII: Best Practice is Adjustment of the Dose for Factor VIII Level?

    C. Kluft, S. Talens

  • Abstract Number: PB2527

    Efficiency of Inhibition of Thrombin Generation and Stimulation of Fibrinolysis in vitro Fertilization Programs

    M. Nikolaeva1,2, A. Momot1,2

  • Abstract Number: PB0730

    Eight Succesfull Pregnancies in Patients with Congenital Fibrinogen Disorders – Single Centre Study

    V. Pohlreichová, I. Čapová, V. Geierová, J. Loužil, E. Ceznerová, R. Kotlín, I. Hrachovinová, P. Salaj

  • Abstract Number: PB0914

    Elbow Embolization for Recurrent Massive Hemarthrosis: A Case Series with Successful Outcome

    S.M. Siboni1, R. Gualtierotti2, S. Braham1, M.E. Mancuso1, E. Biguzzi1, A. Nicolini3, F. Peyvandi1,2

  • Abstract Number: PB1222

    Elderly Patients with Atrial Fibrillation Have Higher Risk of Geriatric Syndromes: Results of the Nursing Study

    I. Tsareva, N. Vorobyeva, G. Semochkina, Y. Kotovskaya, O. Tkacheva

  • Abstract Number: PB1322

    Elevated BAFF Promote B Cell Survival and Autoantibody Production through Upregulating Let-7b in Immune thrombocytopenia

    Y. He, B. Zuo, C. Ruan

  • Abstract Number: PB/LB01

    Elevated BAFF Promote B Cell Survival and Autoantibody Production through Upregulating let-7b in Immune Thrombocytopenia

    Y. He

  • Abstract Number: PB/CO19

    Elevated D-dimers Useful Prediction of Pulmonary Artery Thrombosis in COVID-19 Patients at Initial Presentation to Hospital

    A. Perera1, P. Chowdary2, J. Johnson1, L. Lamb3,4, A. Drebes2, N. Mir5, T. Sood1

  • Abstract Number: PB0114

    Elevated Levels of Activated Factor XII Are Associated with an Increased Risk of Atherothrombotic Events in Peripheral Artery Disease

    B. Kremers1, B. Mees2, J.-W. Daemen2, R. van Oerle1, H. ten Cate1,3,4, A.J. ten Cate-Hoek1,4, H. Spronk1

  • Abstract Number: PB0771

    Elevated Levels of Circulating Markers of Neutrophil Extracellular Traps (NETs) Are Associated with Unfavorable Outcomes in Acute Ischemic Stroke Patients Undergoing Intravenous Thrombolysis

    R. Orbán-Kálmándi1, F. Sarkady1, I. Szegedi2, I. Fekete2, K. Fekete2, L. Csiba2, Z. Bagoly1,3

  • Abstract Number: PB2138

    Elevated Plasma Factor VIII Levels Are Associated with Hypercoagulability and Shorter Survival in Patients with Non-Hodgkin Lymphoma

    C. Moonla1,2, B. Akkawat1,2, A. Sukperm1,2, M. Meesanun1,2, R. Jantasing1,2, T. Chiasakul1,2, N. Uaprasert1,2, P. Rojnuckarin1,2

  • Abstract Number: PB1971

    Elevated Plasminogen Activator Inhibitor Type-1 and Soluble Thrombomodulin of Type 2 Diabetes Mellitus Subjects with Increasing Loss of Glycemic Control in Calabar, Southern Nigeria

    M.S. Edem1, E.C. Akwiwu2, J.O. Akpotuzor2

  • Abstract Number: PB2108

    Elevated Von Willebrand Factor Antigen and Activity Levels Are Risk Factors for Predicting Thrombosis in Cancer

    B. Yan1, W. Du1, T. Hu1, Y. Zhao2, C. Ruan2

  • Abstract Number: PB2264

    Elevated von Willebrand Factor Antigen Levels and Ristocetin Cofactor Activity are Risk Factors in Predicting Deep Vein Thrombosis

    Y. Zhao, X. Zhu, Y. Song, C. Ruan

  • Abstract Number: PB0847

    ELISA-based Quantification of intracellular FVIII Protein in IPS Derived Vascular Endothelial Cells from HA-patients with Nonsense Mutations

    H. Singer, K.J. Czogalla, M. Rath, R. Al-Rifai, M. Jamil, O. El-Maarri, J. Oldenburg

  • Abstract Number: PB1341

    Eltrombopag Suppresses Excessive Inflammation in Hepatitis B-Related Immunologic Thrombocytopenia through Inhibition of Toll-Like Receptor 4 Signaling Pathway

    C. Zhang, S. Ma, J. Peng

  • Abstract Number: PB1355

    Eltrombopag Therapy in Pediatric Acute and Chronic Immune Thrombocytopenia

    M. Azizoğlu, E. Zengin, S. Aylan, Gelen, N. Sarper

  • Abstract Number: PB2068

    Emergency Room Access of Patients on DOACs: A Six Years Single Center Experience

    L. Crippa1, L. Pozzi2, L. Tomassini1, P. Della Valle1, E. Pattarini3, A. Fattorini1, A. D'Angelo1

  • Abstract Number: PB1652

    Emerging Roles of CLEC-2 during Development of Monocrotaline-Induced Liver Injury in Mice

    S. Otake1, T. Shirai2, N. Tsukiji2, T. Sasaki2, K. Takano3, Y. Ozaki4, K. Suzuki-Inoue1,2

  • Abstract Number: PB0977

    Emicizumab and Surgery in Severe Haemophilia A with Inhibitor: Our First Experience

    V. Selvaratnam, F. Rui Jeat, Y. Yee Yee, J. Sathar

  • Abstract Number: PB1164

    Emicizumab beyond Annualized Bleeding Rate: Do Laboratory Assays Help Predict Emicizumab Effects?

    G. Moyer, B.B. Warren, L. Jacobson, C.H. Baird, D. Thornhill, J. Smith, C. Ng, T.W. Buckner, B. Branchford, M. Wang, M.J. Manco-Johnson

  • Abstract Number: PB1165

    Emicizumab beyond Annualized Bleeding Rate: How Does Emicizumab Affect Bone Biomarkers?

    B. Warren1, J. Taylor2, B. Branchford1, C. Ng1, D. Ambruso1, N. Briones1, A. Tran1, L. Jacobson1, D. Thornhill1, G. Moyer1, K. Norton1, T.W. Buckner1, M. Wang1, M.J. Manco-Johnson1

  • Abstract Number: PB0915

    Emicizumab Concentration in Children: A Single Centre Real World Experience

    D. Gosrani1, C. Burgess2, F. Alaoye2, A. Taylor1, K. Sibson1, S. Badle1, A. Barrie1, J. Efford1, J. Spires1, M. Mathias1, R. Liesner1

  • Abstract Number: PB0784

    Emicizumab for the Treatment of Acquired Hemophilia A

    P. Knoebl1, W. Sperr1, P. Jilma2, P. Quehenberger2, K. Gleixner1

  • Abstract Number: PB1141

    Emicizumab in the Management of Hemophilia A: Real World Experience in East Malaysia

    A.S.O. Tang1, S.T. Yeo2, X.Y. Tan3, C.T. Ko4, L.P. Chew5

  • Abstract Number: PB0822

    Emicizumab Prophylactic Therapy in Patients with Hemophilia A Is Better Measured by Thrombin Generation Assay Than Thromboelastography

    E.J. Martin1, J.G. Kuhn2, D.F. Brophy1

  • Abstract Number: PB1081

    Emicizumab Prophylaxis in a Racially Diverse Pediatric Population with Hemophilia A with and without Inhibitors

    J. Garcia, A. Zia

  • Abstract Number: PB0323

    Emicizumab Treatment in Pediatric Patients with Hemophilia A without Inhibitors: A Single-Institution Study

    M. Mori1, C. Nagae2, Y. Umezawa2, A. Sudo2, T. Ashikaga2, A. Yamashita1, M. Taki1

  • Abstract Number: PB1161

    Emicizumab, beyond Annualized Bleeding Rates: Real World Joint Health and Physical Activity Data

    B.B. Warren, D. Thornhill, J. Smith, R. Shearer, G. Moyer, L. Fox, M. O'Connell, R. Horton, S. Funk, A. Chan, E. Gibson, C. Ng, T.W. Buckner, B. Branchford, M.J. Manco-Johnson, M. Wang

  • Abstract Number: PB2427

    EmpoderACO: Elaboration and Validation of a Protocol for Behavioral Change in Patients on Warfarin

    H.C. Barbosa1, A.S. Pagano2, I.A. Reis3, M.F.d.S. Praxedes4, J.M. Da Costa5, H.D.C. Torres6, M.A.P. Martins1,5

  • Abstract Number: PB2125

    Empowering Cancer Patients for Non-Pharmacological Primary Prevention and Early Recognition of Cancer-Associated Thrombosis (CAT): The EMPATIC-CP Survey

    M. Merino1, E. Colomé1, F. Esposito2, C. Beato3, A. Araújo4, Y. De Miguel1, C. Font2

  • Abstract Number: PB0178

    Endocytosis of Factor VIII by Human Dendritic Cells in the Presence of Anti-Factor VIII Antibodies from Patients with Hemophilia A

    M. Bou Jaoudeh1,2, A. Mimoun1,2, V. Daventure2, S. Delignat2, S. Lacroix-Desmazes2

  • Abstract Number: PB0076

    Endogenous PCSK9 Is Related to Circulating CD34bright/CD146– Cells in Patients with Type 2 Diabetes Mellitus

    R. Tripaldi1, P.G.M. Simeone1, P. Lanuti1, R. Liani1, S. Ciotti1, F. Cipollone2, M. Marchisio1, F. Santilli1

  • Abstract Number: PB1982

    Endothelial Protein C Receptor Signaling via Protease-activated Receptor 1 Promotes Neovascularization after Ischemia in Mice

    M. Bochenek1,2, R. Gogiraju2, J. Orth2, S. Großmann2, S. Reyda1, H. Spronk3, T. Münzel2, J. Griffin4, W. Ruf1,5, K. Schäfer2

  • Abstract Number: PB0866

    Endothelial Specific Isoform of Type XVIII Collagen (COL-18N): A Marker of Vascular Integrity in Hemophilic Arthropathy

    N. Abdelhafez1, A. Abdel Gawad Tantawy1, N. Ahmad Safwat2, K. Anwar El Sayed El Seteha3

  • Abstract Number: PB1127

    Endovascular Abdominal Aortic Aneurysm Repair in a Mild Haemophilia A Patient: A Case Report

    M. Rodriguez Lopez, E. Lopez Ansoar, A. Nieto Vazquez, C. Albo Lopez

  • Abstract Number: PB2212

    Endovascular Management with Iliofemoral Stenting in a Patient with Chronic Venous Occlusive Disease and Antiphospholipid Antibodies

    F. Piovella1, D.I. Iosub2, O. Maleti3, M. Lugli3

  • Abstract Number: PB0490

    Enhancing Transfusable Platelets Using mRNA Therapy to Produce Exogenous Proteins

    J. Leung1,2, A. Hagner3, D. Witzigmann1, P. Zandstra2,3, P. Cullis1, C. Kastrup1,2

  • Abstract Number: PB2307

    Epidemiologic Study of Patients with Thrombotic Events Referred to Tertiary Hospital in Southern Iran

    A. Akbari1, S. Haghpanah2, H. Barzegar2, A. Afrasiabi1, S. Parand2, M. Karimi2

  • Abstract Number: PB2250

    Epidemiology and Clinicopathology of Latent versus Active JAK2-Myeloproliferative Neoplasms (MPN) in Splanchnic Venous Thrombosis

    P.A. Haddad, D. Hammoud, K. Gallagher

  • Abstract Number: PB2347

    Epidemiology and Risk Factors for Thrombosis in Pregnancy and Puerperium. Experience in One Reference Center in Mexico

    E. Rojas-Zaldivar1, E.E. Fernández-Velázquez2, G.A. Altamirano-Solórzano1, Á. Cabrera-García3

  • Abstract Number: PB1980

    Epigenetic Regulation of Endothelial Dysfunction in Venous Thromboembolism

    M. Pilard, S. Robin, F. Couturaud, C. Lemarie

  • Abstract Number: PB1629

    Epinephrine Enhances Platelet Aggregation at the Expense of Procoagulant Activity

    A. Aliotta, D. Bertaggia Calderara, M.G. Zermatten, L. Alberio

  • Abstract Number: PB1603

    Essential Thrombocythemia (ET): A Study of Clinical Features and Treatment Outcome in Pediatric Patients at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

    M. Ameen1, A. Almusa2, K. Sidiqui2, M. Alsaleh3, A. Aljefri3

  • Abstract Number: PB2257

    Essential Thrombocythemia Complicated with Portal Vein Thrombosis and Liver Cirrhosis – A Case Report

    N. Petkova1, R. Hristoskova2, D. Danchev3, I. Nikolov1, J. Raynov1

  • Abstract Number: PB0538

    Establishing an External Quality Assessment Scheme (EQAS) for D-Dimer Assay in India: Results from a Pilot

    S. Nair1, V. Gupta1, S. John1, S. Singh1, T. Geevar1, S. Bala1, J. Mammen1, A. Srivastava2

  • Abstract Number: PB1574

    Establishing Reference Intervals for von Willebrand Factor Multimers

    M. Pikta1,2, M. Vasse3, S. Lejniece4,5, K.J. Smock6,7, K.A. Moser6,7, H. Bautista8, G. Nouadje8, V. Banys9

  • Abstract Number: PB0646

    Establishing Reference Range and Validating Precision Performance of the TES-6s System

    M.Y. Lee1, S. Jang2, C.-J. Park2, Y.-U. Cho2

  • Abstract Number: PB0514

    Establishment of a Novel Mixing Test Using Activated Partial Thromboplastin Time (aPTT)-Based Clot Waveform Analysis

    N. Shimonishi1, K. Nogami1, K. Ogiwara1, Y. Oda2, T. Kawabe2, M. Emmi2, M. Shima1

  • Abstract Number: PB0682

    Establishment of Reference Intervals for Automated Light Transmission Aggregometry

    D. Coen Herak1, M. Dolcic2, T. Herceg Brlek3, M. Milos1, I. Lapic1, R. Zadro1,4

  • Abstract Number: PB0521

    Estimation and Analysis of Measurement Uncertainty Acceptability: The Interest of Bayesian Inference

    F. Sobas1, K. Bourazas2, M.O. Geay3, M. Beghin4, E. Jousselme5, C. Nougier5, P. Tsiamyrtzis6

  • Abstract Number: PB2434

    ETNA VTE Europe: A Contemporary Snapshot of VTE Patients Treated with Edoxaban in Clinical Practice across Eight European Countries

    A.T. Cohen1, U. Hoffmann2, P. Hainaut3, S. Gaine4, C. Ay5, M. Coppens6, M. Schindewolf7, D. Jimenez8, B. Brüggenjürgen9, P. Levy10, P. Bramlage11, G. Agnelli12

  • Abstract Number: PB2432

    ETNA-VTE Europe: The Effect of Body Mass Index on 12-Month Outcomes in VTE Patients with Edoxaban

    M. Schindewolf1, B. Brüggenjürgen2, C. Ay3, P. Hainaut4, U. Hoffmann5, S. Gaine6, M. Coppens7, D. Jiménez8, P. Levy9, J. López Bastida10, E. Vicaut11, P. Bramlage12, G. Agnelli13, A.T. Cohen14, ETNA-VTE-Europe Investigators

  • Abstract Number: PB2478

    ETNA-VTE Global: Evaluation of Bleeding Risk Based on VTE-BLEED Score on 12-month Outcomes in a Population Treated with Edoxaban

    A. Cohen1, M. Unverdorben2, C. Chen2, P. Reimitz3, D. Jiménez4,5, G. Agnelli6

  • Abstract Number: PB1424

    Evaluation of 4T Probability Scores, Heparin PF4 Antibody, and Serotonin Release Values in End Stage Renal Disease Patients in the Assessment of Heparin Induced Thrombocytopenia

    J. Kelly1, J. Rimsans1, K. Sylvester1, C. Ting1, T. Bernier1, J.M. Connors2

  • Abstract Number: PB1679

    Evaluation of a New Agonist (ADP-HS®) for Platelet Function Testing with Light Transmittance Aggregometry: A Bi-Center Study

    M. Neuwirth1,2, S. Ambard3, P. Ohlmann4, M. Delrue1,5, N. Itzhar-Baïkian1, P. Gaussem2,6, V. Siguret1,2, M.-C. Alessi3,7,8, A. Stepanian1,5

  • Abstract Number: PB0577

    Evaluation of a New Benzylsulfonyl-D-Arg-Pro-4-Amidinobenzylamide (BAPA) Blood Collection Tube for Platelet Function Studies

    J. Dahlen1, K. Bliden2, U. Tantry2, P. Gurbel2, K. Dobashi3, K. Hosokawa3

  • Abstract Number: PB0665

    Evaluation of a New Device to Remove Direct Oral Anticoagulants (DOACs) from Plasma Samples

    P.O. Sevenet1, T. Hervé1, A. Carlo1, O. Mathieu2

  • Abstract Number: PB1888

    Evaluation of a Rapid, Automated Chemiluminescent ADAMTS-13 Activity Assay for the ACL AcuStar

    R.E. Fretwell, T. Pitchford, S. Cooper, S. Kitchen

  • Abstract Number: PB1850

    Evaluation of Analyser Flag ´Abnormal Platelet Distribution´ in Routine Complete Blood Count (CBC)

    F. Kamal

  • Abstract Number: PB0080

    Evaluation of Biological Effects of Airborne / Urban Pollution Particles

    C. Kluft, K. van Leuven

  • Abstract Number: PB0911

    Evaluation of Bleeding in Haemophilia Carriers by ISTH-BAT: A Single Center Experience

    M. Mortarino1, S.M. Siboni1, I. Garagiola1, M. Boscarino1, F. Peyvandi2

  • Abstract Number: PB1565

    Evaluation of Carriers of Type 3 von Willebrand Disease with PFA200

    T. Geevar1, R. Gautam Dave1, S. Singh1, R. V1, F. N A2, A. Srivastava2, S. C Nair1

  • Abstract Number: PB0341

    Evaluation of Coagulation FIX Binding to Collagen IV and the Impact on Thrombin Generation

    G.B. Morrow1, M.A. Laffan2, N. Curry1,3

  • Abstract Number: PB1398

    Evaluation of Dual Antiplatelet Therapy Combining Aspirin and Clopidogrel for Intracranial Stenting Procedures: A Retrospective Single Center Study

    L. Goncalves, D. Goncalves, C. Monteiro, C. Koch

  • Abstract Number: PB0597

    Evaluation of EQA Material on Lumira Dx Point of Care Platform: UK NEQAS for Blood Coagulation Study

    L. Brown, D. Kitchen, I. Jennings, S. Kitchen, A. Lowe, S. Munroe - Peart, I. Walker

  • Abstract Number: PB0908

    Evaluation of Factors Associated with Extended Half-Life Product Utilization for Men with Hemophilia B Participating in the Community Counts Registry from 2014-2018

    F. Bethea1, C. Kempton2, M. Hayat3

  • Abstract Number: PB0967

    Evaluation of Factors Associated with Prophylaxis Treatment Regimen among Men with Hemophilia B Participating in the Community Counts Registry from 2014-2018

    F. Bethea1, C. Kempton2, M. Hayat3

  • Abstract Number: PB1409

    Evaluation of Fondaparinux (Arixtra®) at a Large Academic Medical Center

    K. Marsh, K. Sessa, Q. Huynh, J. Papadopoulos, D. Green, T. Ahuja

  • Abstract Number: PB0433

    Evaluation of Global Coagulation Assays in Pregnancy

    D. O'Keefe1, H. Nandurkar2, P. Ho3, L. Hui1, H.Y. Lim2,3,4

  • Abstract Number: PB0628

    Evaluation of Hemostatic Markers in Patients with Sickle Cell Disease Using or Not Hydroxyurea

    S.L. Toledo1, M. Oliveira1, L. Ferreira1, V.S. Ladeira2, M.D.G. Carvalho3, L.M. Dusse3, D.R. Rios1, M. Pinheiro1

  • Abstract Number: PB0631

    Evaluation of IgG4 ELISA for the Screening of Factor VIII Inhibitors in Hemophilia A

    N. Awasthi1, K. Riaz1, V. Tiwari2, S. Arshad1, N. Husain1

  • Abstract Number: PB1066

    Evaluation of Inhibitor Risk Prediction Tools Based on Genetic Risk Factors in Persons with Hemophilia A

    A.B. Payne1, C.H. Miller1, D. Ellingsen1, J. Driggers1, C.J. Bean1, J.G. Mulle2,3, J.M. Soucie1, Hemophilia Inhibitor Research Study Investigators

  • Abstract Number: PB0620

    Evaluation of INR and APTTs Using the Q Family of Analysers in Comparison to ACL TOP

    A. Woolley, K. Hickey, M. Bryant, L. Marley, S. Kitchen

  • Abstract Number: PB0841

    Evaluation of Intron 22 and Intron 1 Inversions of Factor VIII Gene in Haemophilia A Patients

    I. Khuwaja1, I.D. Ujjan1, A. Naz2, K. Aamir1

  • Abstract Number: PB0447

    Evaluation of Plasma Level of Soluble CLEC2, a Novel Platelet Activation Marker, in Patients with Sepsis Induced Coagulopathy -A Pilot Study

    H. Ishikura1, Y. Irie1, K. Hoshino1, J. Maruyama1, M. Nakashio1, M. Kawamura2, K. Suzuki-Inoue3

  • Abstract Number: PB1628

    Evaluation of Platelet Count and Platelet Indices of Male Cannabis Sativa (Marijuana) Consumers in Calabar South, Cross River State, Nigeria

    D.C. Okpokam1, M. Nsonko2, A.O. Obembe2

  • Abstract Number: PB2221

    Evaluation of Platelet Indices in Patients with Splanchnic Vein Thrombosis

    N. Kumar1, S. Sharma1, I. Bihana1, V. Uppal1, J. Ahluwalia1, N. Varma1, S. Naseem1, S.K. Sinha2

  • Abstract Number: PB1403

    Evaluation of Platelet Reactivity in Pediatric Patient on Dual Antiplatelet Therapy after Stent Implantation of Ductus Arteriosus: A Case Report

    D. Dineva1, E. Doncheva1, E. Levunlieva2

  • Abstract Number: OC 11.4

    Evaluation of Platelets Activation and Fibrin Clotting in Post-Menopausal Women with Takotsubo Syndrome

    P. Amadio, S.S. Barbieri, B. Porro, S. Eligini, V. Cavalca, S. Barbieri, P.J. Werba, P. Olivares, F. Veglia, E. Tremoli, D. Trabattoni

  • Abstract Number: PB0335

    Evaluation of Structurally Altered Protein in Factor VIII Therapeutic Products Using Chromatography on Immobilized von Willebrand Factor

    H. Chun, J. Pettersson, S. Shestopal, E. Marakasova, T. Lee, A. Sarafanov

  • Abstract Number: PB0449

    Evaluation of the Accuracy of INR Values Measured by a POCT System in a German Clinic with Patients Taking Phenprocoumon as VKA Therapy

    H. Voller1,2, J. Ellis3, J. Loecherbach3

  • Abstract Number: PB0657

    Evaluation of the Atellica® COAG 360 (Siemens Healthineers) at Caen-Normandy University Hospital (FRANCE)

    B. Leroy, M. Brionne-Francois, S. Mesnard, M. Gavard, Y. Repesse

  • Abstract Number: PB0172

    Evaluation of the CEPHEN™ Reagent for the Determination of Activated Partial Thromboplastin Time in Current Practice

    I. Martin-Toutain1, K. Lfadeli1, F. Corre1, M. Lejeune1, G. Nguyen1, J.-P. Delorme2, Y. Bourti2, C. Frere1,3

  • Abstract Number: PB0342

    Evaluation of the Effect Emicizumab Neutralizing Antibodies on aPTT Clotting-based Tests Results in Patients Treated with Emicizumab

    C. Novembrino1, M. Boscolo-Anzoletti1, F. Rossi1, E. Mancuso1, S. Shinohara2, F. Peyvandi1,3

  • Abstract Number: PB0516

    Evaluation of the Newly-developed Collagen Induced Platelet Aggregation Level (CPAL) System in Aggregometer on Automated Coagulation Analyzer

    K. Kitano1, K. Uematsu2,3, T. Sakayori1, Y. Omori4, H. Ishida4, N. Arai1, H. Matsubara3, Y. Komiyama5, Y. Enomoto3

  • Abstract Number: PB1175

    Evaluation of the Potential Utility of the Total Thrombus-Formation Analysis System (T-TAS) in Comparison to the Platelet Function Analyzer (PFA) in Subjects with Primary Hemostatic Defects

    J. Charpy1, N. Benattar2, P.-E. Chaghouri1, S.-M. Castet3, Y. Huguenin3, C. James1, M. Fiore4

  • Abstract Number: PB0037

    Evaluation of the Selectivity of BCR-ABL Tyrosine Kinase Inhibitors (TKIs): A Systematic Review

    H. Haguet1, C. Challe2, Y. Nezzar2, F. Mullier3, C. Graux3, J.-M. Dogné1, J. Douxfils1,4

  • Abstract Number: PB1213

    Evaluation of the Skeletal Lesions in the Lebanese Patients with Afibrinogenemia

    C. Djambas Khayat1, T. Younane2

  • Abstract Number: PB0627

    Evaluation of the Succeeder SF-8200 Fully Automated Coagulation Analyzer

    O. Zengi, A. Kirankaya, S.H. Kucuk, T. Sarac

  • Abstract Number: PB2428

    Evaluation of Thrombin and Fibrin Generation in Venous Thromboembolism (VTE) Patients Receiving Anticoagulation

    J. Wang1,2, H.Y. Lim1,2, R. Brook1, O. Aswapanyawongse2, P. Ho1,2

  • Abstract Number: PB1375

    Evaluation of Thrombocytopenia and Fetomaternal Outcome in Pregnancy at a Tertiary Care Hospital

    K. Aamir1, I. Ujjan1, A. Naz2

  • Abstract Number: PB0640

    Evaluation of Thrombogenicity of Apheresis-collected Platelet Concentrates under Blood Flow Condition

    T. Nagasato1, T. Ohnishi-Wada1, H. Sameshima-Kaneko1, C. Oyamada1, K. Hosokawa1, Y. Matsubara2

  • Abstract Number: PB0476

    Evaluation of Thrombomodulin Levels in Women with Breast Cancer Undergoing Doxorubicin Treatment

    M. Teodoro Alves Vieira1, R. Simões2, L.M. Silva3, H.H. Oliveira3, I.D. Souza1, M.D.G. Carvalho1, L.M. Dusse1, A.D.P. Sabino1, R.M. Pestana1, K.B. Borges1

  • Abstract Number: PB0255

    Evolutionary History of the Kallikrein-Kinin System and Factor XI

    M. Ponczek1, C. Kastrup2, A. Shamanaev3, K. Dickeson4, B.M. Mohammed4, A.R. LaPlace4, M.-F. Sun4, Q. Cheng4, A. Gruber5, J. Emsley6, D. Gailani4

  • Abstract Number: PB0817

    Examining the Hemophilia Disability Paradox

    D. Nugent1, J. O'Hara2, A. Martin3, G. Morgan3, T. Buckner4, M. Skinner5,6, B. O'Mahony7,8, B. Mulhern9, E.K. Sawyer10, N. Li10

  • Abstract Number: PB1526

    Excessive Angiogenesis in von Willebrand Factor Knockout Mice is Accompanied by Increased Perivascular Coverage of Neovessels

    L. Sommerville1, J. Xu1, D. Monroe2, M. Hoffman1,3

  • Abstract Number: PB0611

    Excluding Anticoagulants and Antiplatelet Drugs with Rotational Thromboelastometry

    A.-M. Hulshof, R. Olie, M. Vries, P. Verhezen, R. Wetzels, H. ten Cate, Y. Henskens

  • Abstract Number: PB1627

    Exercise Training Enhances Mitochondrial Bioenergetics of Platelets in Patients with Peripheral Arterial Disease

    J.-S. Wang

  • Abstract Number: OC 05.4

    Exogenous Microparticles Bearing Tissue Factor Improve Outcome After Collagenase-Induced Intracranial Hemorrhage

    F. Potzeha, M. Yetim, D. Vivien, T. Gaberel, M. Gauberti, S. Martinez de Lizarrondo

  • Abstract Number: PB0500

    Exome-array Analysis of Plasma Hemostatic Factors D-dimer, tPA and PAI-1 Identifies Novel Genes

    F. Thibord1, C. Song1, M.-H. Chen1, B.A.T. Rodriguez1, L.R. Yanek2, M. Sabater-Lleal3, G.D. Carrasquilla4, L. Hampton5, J.I. Rotter6, K.C. Desch7, P. Morange8, M.E. Kleber9, N.L. Smith10, A.C. Morrison11, A.D. Johnson1

  • Abstract Number: PB1293

    Expanding the Spectrum of Heterozygous Antithrombin Deficiency Type II HBS? Unusual Presentation of Thromboembolic Events in Two Children

    K. Beutel1, S. Liptay1, C. Makowski1, S. Eber1,2, M.-M. Steinborn3

  • Abstract Number: PB1099

    Expectations and Concerns of Patients with Haemophilia towards Gene Therapy – Results of Patients and Expert Focus Groups

    S. von Mackensen

  • Abstract Number: PB0790

    Experience with Recombinant Porcine FVIII in Patients with Acquired Factor VIII Deficiency Undergoing Major Surgery

    M. Escobar, N. Montanez, I. Aboshady, K. Chong

  • Abstract Number: PB1527

    Explanations for Rise of Levels of Factor VIII and von Willebrand Factor Antigen with Age

    E. Biguzzi1,2, F. Castelli1, W.M. Lijfering1, S.C. Cannegieter1, J. Eikenboom3, F.R. Rosendaal1, A. van Hylckama Vlieg1

  • Abstract Number: PB1861

    Exploration of Coagulation Disorders, von Willebrand Factor and ADAMTS13 in a Cohort of 45 Patients with Hemophagocytic Lymphohistiocytosis

    A. Launois1,2, S. Valade3, E. Roose4, E. Mariotte3, M. Darmon3, L. Galicier5, L. Zafrani3, V. Lemiale3, E. Azoulay3, S. Mathis6, I. Kalidi6, A. Stepanian1,2, K. Vanhoorelbeke4, A. Veyradier1,2, B. Joly1,2

  • Abstract Number: PB2201

    Exploring Alternative Approaches of Using the Villalta Scale to Capture the Post-Thrombotic Syndrome: A Sub-analysis of the ATTRACT Trial

    S.R. Kahn1, C.-S. Gu2, J.-P. Galanaud3, C. Kearon4, S. Vedantham5, for the ATTRACT Trial

  • Abstract Number: PB1105

    Exploring RNA Editing System as Innovative Correction Strategy for Hemophilia A

    S. Pignani, G. Roman, S. Buzzi, G.E. Walker, A. Follenzi

  • Abstract Number: PB0404

    Exploring the Effectiveness of DNA and Glycosaminoglycans as Inhibitors of Histones

    N. Sharma, L. Haggstrom, S. Sohrabipour, D.J. Dwivedi, P.C. Liaw

  • Abstract Number: PB0813

    Exploring the Relationship between Common Complications of Haemophilia and Anxiety and Depression in People with Haemophilia A

    T. Burke1,2, E. Ferri Grazzi1,2, A. Shaikh1,2, C. Hawes3, C. Camp3, J. O'Hara1,2

  • Abstract Number: PB0804

    Exploring the Relationship between Condition Severity and Health-Related Quality of Life in Haemophilia A

    T. Burke1,2, E. Ferri Grazzi1,2, A. Shaikh1,2, C. Hawes3, C. Camp3, J. O'Hara1,2

  • Abstract Number: PB0375

    Expression of Circulating Microparticles Procoagulant Activity in Cirrhotic Patients

    B. Mejda1, B. Hela1, B. Dhouha1, L. Asma2, J. Boubaker2, B.R. Neila1

  • Abstract Number: PB1956

    Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes

    N. Ziliotto1, G. Marchetti2, S. Meneghetti1, E. Menegatti3, M. Baroni1, B. Lunghi1, F. Salvi4, M. Ferracin5, A. Branchini1, D. Gemmati2, F. Mascoli6, P. Zamboni3, F. Bernardi1

  • Abstract Number: PB1132

    Extended Half-life FIX and Disruptive Therapies in Carriers with FVIII and FIX Deficiencies: Preliminary Experience

    C. Hermans, C. Lambert

  • Abstract Number: PB0890

    Extended Half-Life of the Double-Chain Recombinant Factor VIII-Fc Fusion Protein (FRSW107) in Previous Treated Hemophilia A Patients

    F. Xue1, Y. Chen2, Q. Wen2, J. Sun3, C. Xu3, X. Zhang4, H. Sun1, Y. Wang2, H. Su5, R. Yang1

  • Abstract Number: PB2455

    Extended Treatment in Unprovoked Venous Thromboembolism: What Is Important to Patients?

    A. van de Brug, M.A. de Winter, H.A.H. Kaasjager, M. Nijkeuter

  • Abstract Number: PB0453

    Extensive Characterization of the Hemostatic Changes during Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Peritoneal Carcinomatosis

    P. Gomez Rosas1,2, N.F.J. Schillaci1, M. Marchetti1, L. Russo1, S. Gamba1, C. Verzeroli1, C. Giaccherini1, C.J. Tartari1, A. Vignoli1, S. Magnone3, A. Falanga1,4

  • Abstract Number: PB0533

    Extensive Experiments in (Un)Diagnosed Bleeding Patients with Prolonged Platelet Function Analyser Closure Times

    F. Heubel-Moenen1, F. Swieringa2, L. Herfs3, M. Sims4, K. Downes4, D. Greene4, R. Wetzels5, P. Verhezen5, P. Machiels3, W. Ouwehand6, J. Heemskerk2, E. Beckers1, Y. Henskens5

  • Abstract Number: PB0274

    External Quality Assurance (EQA) for the Thromboelastometry Devices: UK NEQAS BC Programme Update

    D.P. Kitchen, L. Brown, S. Munroe-Peart, A. Lowe, I. Jennings, S. Kitchen, I. Walker

Jump to:  View All • a b c d [e] f g h i j k l m n o p q r s t u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2021 John Wiley & Sons, Inc. All Rights Reserved.
Wiley
This site uses cookies: Find out more.